This inventor holds 1 USPTO granted patent. Top assignee: Eberhard-Karls-Universitat Tubingen. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: The Innovations of Irene Rappold
Introduction
Irene Rappold is a notable inventor based in Tubingen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for medical research and therapeutic applications.
Latest Patents
Irene Rappold holds a patent for the monoclonal antibody designated as 4G8B4B12. This invention specifically binds to the human FLT3/FLK2 receptor protein. The patent also encompasses hybridoma cells that produce this antibody, along with a method for generating such hybridoma cells. The monoclonal antibody is produced and released by hybridoma cells deposited under No. DSM 2249 at the German Collection of Microorganisms and Cell Cultures (DSMZ).
Career Highlights
Irene Rappold is affiliated with Eberhard Karls University of Tubingen, where she conducts her research. Her work has been instrumental in advancing the understanding of receptor proteins and their role in various biological processes.
Collaborations
Irene collaborates with Hans-Jorg Buhring, contributing to the advancement of their shared research interests in biotechnology and antibody development.
Conclusion
Irene Rappold's innovative work in monoclonal antibodies exemplifies the impact of research on medical science. Her contributions continue to influence the field and pave the way for future advancements.